BD Touchless Plus Unisex Pre-Lubricated Urethral Catheter Kit
C.R. Bard, Inc. · Decision date May 29, 2026
What did the FDA decide?
FDA records K254076 as a 510(k) premarket notification, with a decision dated May 29, 2026. The decision code in the record is SESK.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- May 29, 2026
Regulatory record facts
- Identifier
- K254076
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- C.R. Bard, Inc.
- Product code
- FCM
- Decision code
- SESK
- Decision date
- May 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tray, Catheterization, Sterile Urethral, With Or Without Catheter (Kit).
- Applicant
- C.R. Bard, Inc.
- Product code
- FCM
- FDA device class
- 2
FDA decision timeline
K254076 received
Application receipt date recorded by FDA.
K254076 · FDA decision
SESK
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
C.R. Bard, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Covington, GA
Sources and methodology
- Original FDA record: K254076
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records